EP12.01. Durable Response to High-Dose Aumolertinib 165mg After Local Progression in EGFR-Mutated Non-Small Cell Lung Cancer with Brain Metastases - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Qingqing Zhu
Meta Tag
Speaker Qingqing Zhu
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
case report
WCLC 2023 conference
high-dose aumolertinib
metastatic non-small cell lung cancer
brain metastases
EGFR exon 19 deletion mutation
partial response
complete response
local progression
Powered By